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Ah&act This in situ hybridization study describes the developmental appearance of the lobular distribution of the mRNA encoding hepatic 
glutaminase in normal rat liver. Glutaminase has been proposed to provide the urea cycle with ammonia [Hiiussinger and Gerok (1983) Eur. J. 
Biochem. 133,26%275]. Hence, the (developmental) pattern of expression of the mRNA would be expected to be closely linked to that of the urea 
cycle enzymes. From embryonic day 20 onward, hepatic glutaminase mRNA can be detected along the entire porto-central axis, with predominant 
expression in the portal area. In the adult phenotype, which is acquired at the end of the first postnatal week, glutarninase mRNA is no longer present 
along the entire porto-central distance but has become confined to a relatively small periportal domain in which the expression decreases in a 
porto-central direction. Thus, in contrast to the large periportal domain, in which the urea cycle enzymes are expressed, the glutaminase mRNA- 
expressing domain is much smaller and not contiguous with the glutamine synthase mRNA-expressing pericentral domain, leaving a midlobular 
area that is devoid of glutaminase mRNA. A similar pattern of distribution was found in adult mouse liver. The significance of these observations 
is that, within the liver lobules, there is an area in which glutaminase is not expressed and, hence, glutamine can not be the substrate for urea synthesis. 
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1. Introduction 
Hepatocytes in the adult mammalian liver are arranged in 
regular functional units or ‘metabolic lobules’ [l]. The presence 
of an upstream periportal and a downstream pericentral do- 
main in these units suggests that the molecular phenotype of 
a particular hepatocyte depends on its position on the porto- 
central axis. However, the confines of these domains are dy- 
namic and depend on the metabolic state of the animal [2]. 
The homeostatic function of the liver requires that the oppo- 
site processes have to be performed within the same organ. In 
the mammalian liver such opposite processes are spatially 
separated, occupying either the periportal or the pericentral 
domain. Thus, gluconeogenesis, urea synthesis and glutamine 
hydrolysis predominate in the upstream domain, whereas gly- 
colysis and glutamine synthesis are predominant in the down- 
stream region [2,3]. 
A unique isoform of glutaminase is expressed in the liver, the 
ammonia-activated glutaminase (EC 3.5.1.2) [4]. This enzyme 
hydrolyses glutamine into ammonia and glutamate, important 
substrates for ureagenesis and gluconeogenesis [5]. Hence, it 
would be expected that hepatic glutaminase is localized to a 
similar region in the lobule as the urea cycle enzymes, particu- 
larly carbamoylphosphate synthase (I) which fixes ammonia 
into carbamoylphosphate, and phosphoenolpyruvate car- 
boxykinase, the marker enzyme for gluconeogenesis. Carbam- 
oylphosphate synthase (I) protein [6] and mRNA [7] have been 
shown to be localized in a large periportal domain that is 
contiguous with the small glutamine synthetase-expressing per- 
icentral domain. Phosphoenolpyruvate carboxykinase protein 
[8] and mRNA [9,10] are also present in a periportal area which 
is, however, not as large as that of the urea cycle enzymes. 
*Corresponding author. Fax: (31) (20) 697 6177. 
There is functional evidence that glutaminase is predomi- 
nantly present in the periportal hepatocytes [ 111, and it has been 
shown that isolated periportal hepatocytes have a 2-3 fold 
higher glutaminase activity and mRNA level than pericentral 
hepatocytes [ 121. However, the digitonin/collagenase perfusion 
technique used to isolate periportal and pericentral hepatocytes 
does not permit the establishment of the precise intralobular 
extent of the glutaminase-expressing periportal domain in rela- 
tion to other marker enzymes/mRNAs. To this end we have 
carried out an in situ hybridization study to unambiguously 
localize the glutaminase mRNA-expressing domain in normal 
adult rat liver in relation to other marker mRNAs encoding 
glutamine synthase and carbamoylphosphate synthase (I). 
2. Materials and methods 
2.1. Animals 
Wistar rats and Swiss mice were obtained from the HSD animal farm 
(Zeist, The Netherlands) and maintained on a standard diet and water 
ad libitum. Fetal and neonatal age were calculated from dated matings 
and time of birth, respectively. Adult mice and rats were approximately 
3 months of age. 
2.2. Hybridocytochemicai analysis 
Formalin fixation, paraffi embedding and sectioning, pretreatment 
of the sections, hybridization conditions, and signal visualization have 
been described in detail [13]. At variance to this protocol riboprobes 
were used rather than cDNA probes. Consequently, hybridization and 
wash temperatures were raised to 54°C and an additional incubation 
with RNase A (10 &/ml) for 30 min at 37“C was included after the 
second wash. 
a-“S-Labelled transcripts were made by in vitro transcription of 
linearized pBluescript in which the appropriate restriction fragment 
was subcloned. As probes for the detection of hepatic glutaminase, 
carbamoylphosphate synthase, glutamine synthase and albumin 
mRNAs, the following sequences were used, respectively: (i) the entire 
insert (1000 bp) of the hepatic glutaminaae cDNA clone [14], (ii) the 564 
bp BumHI-SmuI DNA fragment localized at position 719-1283 of the 
carbamoylphosphate synthase (I) cDNA clone CF’S-KdG [IS], (iii) the 
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1025 bp k@-TaqI DNA fragment local&d at position 235-1260 of 
the glutamine synthase cDNA clone pGS4 clone [lq, and (iv) the entire 
insert (1034 bp) of the albumin cDNA clone ALBl [17]. To allow 
efficient hybridization, RNA transcripts longer than 200 nucleotides 
were subjected to alkaline hydrolysis to yield fragments of a mean size 
of 100-150 nucleotides as asses& by polyacrylamide gel-electro- 
phoresis. Probe concentration was approximately 30 pg (specific activ- 
ity 1700 cpm/pg) per ~1 hybridization solution, and approx. 6~1 hybrid- 
ization mixture was applied per section. No coverslips were used to 
improve fficiency of hybridization and to allow easy comparison of 
serial sections incubated with different probes and controls. 
3. Results 
Hybridization to a-3’S-labelled probes was visualized by 
bright-field microscopy, revealing positive signals as black sil- 
ver grains. The distinct patterns of hybridization obtained with 
the different probes are considered important tissue-intrinsic 
controls that are imperative for reliable mRNA localizations 
[13]. Fig. 1 demonstrates that specific hybridization is being 
achieved. In agreement with previous work [14], glutaminase 
mRNA could not be detected in fetal liver and other tissues, 
such as spinal cord, kidney and intestine, whereas albumin 
mRNA (that served as a positive control) was found to be 
exclusively expressed in the liver. 
3.1. Development appearance 
Up until 18 days of development hepatic glutaminase mRNA 
can not be detected in liver or other organs. At embryonic day 
20, glutaminase mRNA can first be detected (Fig. 2a): it is 
present in all hepatocytes, but the density of grains decreases 
in the porto-central direction. Glutamine synthase mRNA (Fig. 
2b), that at this stage is still expressed in all hepatocytes (cf. 
[18]), is present in a central-to-portal gradient and as such 
identities the central venules. In newborn rat liver glutaminase 
mRNA is strongly expressed in all hepatocytes and a clear 
porto-central gradient can be recognized (Fig. 2~). From this 
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stage onwards glutamine synthase mRNA is strongly expressed 
in a small pericentral area only (Fig. 2d,f). 5 days after birth 
the adult pattern of expression has almost been achieved and 
glutaminase mRNA is no longer expressed in all hepatocytes 
(Fig. 2e). 
3.2. The adult pattern of expression 
In adult rat liver, glutaminase mRNA is present in a clearcut 
porto-central gradient, background levels being reached mid- 
way along the porto-central distance (Fig. 3a). Its domain of 
expression is therefore not contiguous with the pericentral glu- 
tamine synthase-expressing area (Fig. 3b) and is distinctly 
smaller than that of carbamoylphosphate synthase (Fig. 3~). A 
similar pattern of expression is observed in adult mouse liver 
(Fig. 3d and e). 
4. DlWussion 
The mammalian liver plays an important role in the regula- 
tion of circulating glutamine levels as it has the capacity for 
both glutamine synthesis and glutamine degradation. In iso- 
lated perfused liver, pericentral glutamine synthesis and peri- 
portal glutamine degradation take place simultaneously due to 
the concurrent action of p&centrally localized glutamine syn- 
thase and periportally localized glutaminase [11,191. This study 
shows that the mRNAs encoding glutaminase and glutamine 
synthase are expressed in distinct periportal and p&central 
populations of hepatocytes, respectively. Previously, it was 
demonstrated that glutaminase mRNA is two-fold enriched in 
isolated periportal hepatocytes [12]. However, the techniques 
used to separate periportal and pericentral hepatocytes do not 
permit the zonation of a particular mRNA or protein to be 
accurately established. To this end in situ hybridization or 
immunohistochemistry is a more suitable technique. 
This study shows that there is no overlap in the expression 
Fig. 1. Absence of hepatic glutaminase mRNA from fetuses of 18 days of development. Serial sections were allowed to hybridize with “S-labelled 
probes for hepatic glutaminase mRNA (a) and, as a positive control, albumin mRNA (b). SC, spinal cord; k, kidney; i, intestine; 1, liver. 
Bar=200~. 
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Fig. 2. Ontogenesis of glutamk+se mRNA heterogeneity in developing liver. Hybridization analysis was carried out on liver sections of 20-day-old 
fetuses (a,b), and of neonates at 2.5 h (c,d) and 5 days (e,f) after birth. Sections were allowed to hybridize with ‘sS-labelled probes for hepatic 
glutaminase mRNA (a,c,e) and, to identify the central venules, glutamine synthase mRNA (b,d,f). p, portal venule; c,central venule. Bar = 500 pm. 
of the mRNAs encoding glutaminase and glutamine synthase. 
On the contrary, in between the glutaminase mRNA-expressing 
periportal domain and the glutamine synthase-expressing per- 
icentral domain there is a zone where neither glutaminase 
mRNA nor glutamine synthase mRNA is expressed but in 
which the mRNA encoding the ammonia4xing enzyme car- 
bamoylphosphate synthase (I) is expressed. A similar pattern 
of expression was found in adult mouse liver. The relatively 
small periportal zone of glutaminase expression explains the 
high ratio of glutaminase mRNA concentration that is found 
in isolated periportal and pericentral cells [12]. 
For several reasons the observations presented here were 
unexpected. (i) Hydrolysis of glutamine by the action of glu- 
taminase yields the substrates for the intimately associated glu- 
coneogenic and ureagenic pathways (see [20] for a review). 
(ii) Glutamine-derived ammonia has been shown to be the pref- 
erential substrate for carbamoylphosphate synthase (I) [21]. 
(iii) Both glutaminase [22] and carbamoylphosphate synthase 
(I) [23] share a mitochondrial localization and are closely 
linked with the mitochondrial inner membrane. (iv) The peri- 
portally localized glutaminase would raise the intramitochon- 
drial ammonia concentration and, hence, facilitate the channel- 
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Fig. 3. Adult pattern of glutaminase mRNA (a,d) compared with that of glutamine synthase mRNA (b,e) and carbamoylphosphate synthase mRNA 
(c) in rat (a,b,c) and mouse (d,e) liver. p, portal venule; c, central venule. Bar = 500 ,um. 
ing of ammonia into the urea cycle by carbamoylphosphate 
synthase that has a relatively low affinity for ammonia [19,24]. 
(v) In line with these ideas, the urea cycle enzymes, glu- 
coneogenic enzymes and hepatic glutaminase share a compara- 
ble pattern of regulation by diet and hormones, and all show 
a strong upsurge in the first postnatal week ([ 14,25-301 and this 
study). 
Despite this common pattern of regulation, and the common 
subcellular localization of glutaminase and carbam- 
oylphosphate synthase, the periportal domain expression of 
hepatic glutaminase mRNA is much smaller than that of car- 
bamoylphosphate synthase and more like that of 
phosphoenolpyruvate carboxykinase [9,10,31]. The functional 
significance of this remarkable difference is puzzling, since it 
raises the question of how the low-affinity carbamoylphosphate 
synthase is provided with sufficient ammonia. Obviously, met- 
abolic studies are required to elucidate the handling of ammo- 
nia in the ‘glutaminase-free’ midlobular zone of the liver. 
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